4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
4: Statement of changes in beneficial ownership of securities-Director KOZARICH JOHN W
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sabba Stephen L
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Aryeh Jason
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Korenberg Matthew E
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Espinoza Octavio
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Davis Todd C
Ligand Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Macquarie Group Limited(5.66%),Macquarie Management Holdings Inc(5.66%), etc.
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(10.76%)
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(7.7%),Janus Henderson Triton Fund(5.1%)
Ligand Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(6.8 %),GOLDMAN SACHS & CO. LLC(6.8 %)
Ligand Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(17.0%)
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Reardon Andrew
Ligand Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Financial Officer Espinoza Octavio
No Data